{"id":210884,"date":"2017-02-24T02:40:33","date_gmt":"2017-02-24T07:40:33","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/edap-tms-s-a-edap-announces-prelim-q4-revenue-of-eur10-streetinsider-com.php"},"modified":"2017-02-24T02:40:33","modified_gmt":"2017-02-24T07:40:33","slug":"edap-tms-s-a-edap-announces-prelim-q4-revenue-of-eur10-streetinsider-com","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/tms\/edap-tms-s-a-edap-announces-prelim-q4-revenue-of-eur10-streetinsider-com.php","title":{"rendered":"EDAP TMS S.A. (EDAP) Announces Prelim. Q4 Revenue of EUR10 &#8230; &#8211; StreetInsider.com"},"content":{"rendered":"<p><p>Get daily under-the-radar research with StreetInsider.com's  Stealth Growth Insider   Get your 2-Wk Free Trial here.    <\/p>\n<p>    EDAP Announces Preliminary Unaudited Full Year 2016    Revenue  <\/p>\n<p>    EDAP TMS SA (NASDAQ: EDAP), the global leader in    therapeutic ultrasound, announced today that its unaudited    Fourth Quarter 2016 revenue is estimated to be 10.7 million    and its full year 2016 revenues to be around 35.6 million, an    increase of 10% as compared to revenue of 32.3 million for the    full year 2015.  <\/p>\n<p>    The Company estimates that as of December 31, 2016, it had 22    million of cash on hand.  <\/p>\n<p>    Marc Oczachowski, Chief Executive Officer, commented: \"We are    pleased with our 2016 revenue and EDAP's continued growth,    mainly driven by 63% growth in our HIFU division. With 22    million of cash on hand at the end of the year, we are well    positioned to pursue our development programs and marketing    expansion strategy to make our innovative HIFU technology    available worldwide.\"  <\/p>\n<p>    The Company also announced that it will report fourth quarter    and full year 2016 results after the close of the market on    Monday, April 3rd, 2017. An accompanying conference call will    be hosted by Marc Oczachowski, CEO and Francois Dietsch, Chief    Financial Officer at 8:30 AM ET on Tuesday, April 4th, 2017.    Please refer to the information below for conference call    dial-in information and webcast registration.  <\/p>\n<p>    Conference Details  <\/p>\n<p>    Conference Date: Tuesday, April 4th, 2017 8:30    AM ET  <\/p>\n<p>    Conference dial-in: 877-269-7756  <\/p>\n<p>    International dial-in: 201-689-7817  <\/p>\n<p>    Conference Call Name: EDAP-TMS Fourth Quarter    and Full Year 2016 Results Call  <\/p>\n<p>    Webcast Registration: Click Here  <\/p>\n<p>    Following the live call, a replay will be available on the    Company's website, <a href=\"http:\/\/www.edap-tms.com\" rel=\"nofollow\">http:\/\/www.edap-tms.com<\/a> under    \"Investors Information.\"  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Originally posted here:<\/p>\n<p><a target=\"_blank\" rel=\"nofollow\" href=\"http:\/\/www.streetinsider.com\/Guidance\/EDAP TMS S.A. (EDAP) Announces Prelim. Q4 Revenue of EUR10.7M\/12582617.html\" title=\"EDAP TMS S.A. (EDAP) Announces Prelim. Q4 Revenue of EUR10 ... - StreetInsider.com\">EDAP TMS S.A. (EDAP) Announces Prelim. Q4 Revenue of EUR10 ... - StreetInsider.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. EDAP Announces Preliminary Unaudited Full Year 2016 Revenue EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, announced today that its unaudited Fourth Quarter 2016 revenue is estimated to be 10.7 million and its full year 2016 revenues to be around 35.6 million, an increase of 10% as compared to revenue of 32.3 million for the full year 2015. The Company estimates that as of December 31, 2016, it had 22 million of cash on hand <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/tms\/edap-tms-s-a-edap-announces-prelim-q4-revenue-of-eur10-streetinsider-com.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[431603],"tags":[],"class_list":["post-210884","post","type-post","status-publish","format-standard","hentry","category-tms"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/210884"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=210884"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/210884\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=210884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=210884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=210884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}